01 17GlaxoSmithKline Inc.
01 52417825
02 62458534
03 32564742
04 32781487
01 8FLUTICASONE FUROATE | UMECLIDINIUM BROMIDE | VILANTEROL TRIFENATATE
02 6Fluticasone Furoate | Vilanterol
03 3UMECLIDINIUM BROMIDE | VILANTEROL TRIFENATATE
01 15POWDER
02 2Powder
01 52021-08-03
02 62022-09-11
03 32025-04-27
04 32030-11-29
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2458534
Filing Date : 2002-09-11
Strength per Unit : 100 mcg / 25 mcg
Dosage Form : Powder
Human Or VET : Human
Route of Administration : Oral Inhalation
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2417825
Filing Date : 2001-08-03
Strength per Unit : 100 mcg / 25 mcg
Dosage Form : Powder
Human Or VET : Human
Route of Administration : Oral Inhalation
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Patent Expiration Date : 2025-04-27
Date Granted : 2012-01-10
Umeclidinium Bromide, Vilanterol Trifenatate
Brand Name : ANORO ELLIPTA
Patent Number : 2564742
Filing Date : 2005-04-27
Strength per Unit : 62.5 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-04-27
Date Granted : 2012-01-10
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Umeclidinium Bromide, Vilanterol Trifenatate
Brand Name : ANORO ELLIPTA
Patent Number : 2458534
Filing Date : 2002-09-11
Strength per Unit : 62.5 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2417825
Filing Date : 2001-08-03
Strength per Unit : 200 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : INHALATION
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2458534
Filing Date : 2002-09-11
Strength per Unit : 200 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : INHALATION
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2417825
Filing Date : 2001-08-03
Strength per Unit : 200 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Fluticasone Furoate, Vilanterol Trifenatate
Brand Name : BREO ELLIPTA
Patent Number : 2458534
Filing Date : 2002-09-11
Strength per Unit : 200 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-09-11
Date Granted : 2011-11-01
Patent Expiration Date : 2030-11-29
Date Granted : 2018-10-16
Umeclidinium Bromide, Vilanterol Trifenatate
Brand Name : ANORO ELLIPTA
Patent Number : 2781487
Filing Date : 2010-11-29
Strength per Unit : 62.5 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-11-29
Date Granted : 2018-10-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate
Brand Name : TRELEGY ELLIPTA
Patent Number : 2417825
Filing Date : 2001-08-03
Strength per Unit : 100 mcg / 62.5 mcg / 25 mcg
Dosage Form : POWDER
Human Or VET : Human
Route of Administration : INHALATION
Patent Expiration Date : 2021-08-03
Date Granted : 2008-07-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
